Journal of Surgical Research
Volume 157, Issue 1 , Pages e31-e37, November 2009

AP-1 Inhibits Expression of MMP-2/9 and Its Effects on Rat Smooth Muscle Cells

  • Hong-Wei Zhang, Ph.D.

      Affiliations

    • Veteran Carder Clinic, the First Affiliated Hospital, China Medical University, Liaoning, China
  • ,
  • Xin Wang, Ph.D.

      Affiliations

    • Veteran Carder Clinic, the First Affiliated Hospital, China Medical University, Liaoning, China
  • ,
  • Zhi-Hong Zong, Ph.D.

      Affiliations

    • Department of Biochemistry, China Medical University, Liaoning, China
  • ,
  • Xin Huo, Ph.D.

      Affiliations

    • Veteran Carder Clinic, the First Affiliated Hospital, China Medical University, Liaoning, China
  • ,
  • Qiang Zhang, Ph.D.

      Affiliations

    • Veteran Carder Clinic, the First Affiliated Hospital, China Medical University, Liaoning, China
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Veteran Carder Clinic, The First Affiliated Hospital, China Medical University, Shenyang 110001, Liaoning, China.

Received 5 December 2008 published online 16 March 2009.

Background

We designed AP-1 small interfering RNA (siRNA) to study the relationship between AP-1 expression and matrix metalloproteinase (MMP)-2 activation.

Methods

To suppress the expression of AP-1 gene, we used RNA interference to silence the AP-1 gene post-transcriptionally in rat smooth muscle cells. Effects of AP-1 siRNA on mRNA expression of AP-1 were examined using reverse transcriptase polymerase chain reaction (RT-PCR). Phosphorylation levels of c-Jun, c-Fos, and the activity of AP-1 were determined by Western blotting and AP-1 DNA-binding activity assay. To observe the expression of SM α-actin and downstream genes of AP-1, we simultaneously examined the activity of cell matrix metal proteinases and the migration ability of smooth muscle cells using a modified Boyden-chamber assay. Effects of AP-1 siRNA on rat vascular smooth muscle cells (VSMC) in vitro were evaluated using cell cycle analysis, MTT-tests, BrdU-ELISA and immunofluorescence.

Results

AP-1 siRNA decreased not only AP-1 mRNA and AP-1 binding activity, but also c-Jun and c-Fos phosphorylation levels and the expression levels of urokinase-type plasminogen (u-PA), MMPs, TGF-β1 and bFGF in VSMCs. The AP-1 siRNA also significantly inhibited PDGF/IL-1-induced MMP-2 and MMP-9 gelatinolytic activity in VSMCs. The invasion and migration of VSMC were also induced greatly.

Conclusions

AP-1 inhibited expression of MMP-2/9 and AP-1 siRNA was able to effectively inhibit the proliferation, migration and de-differentiation of rat smooth muscle cells.

Key Words: AP-1, vascular smooth muscle cells, invasion, MMP-2, MMP-9, AP-1siRNA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-4804(09)00058-4

doi:10.1016/j.jss.2009.02.015

Journal of Surgical Research
Volume 157, Issue 1 , Pages e31-e37, November 2009